In vivo effects of cocaine on immune cell function

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 139-147

  Pellegrino, Trisha ^a   Bayer, Barbara M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cellular immunity; Cocaine; Humoral immunity; In vivo

Indexed keywords

COCAINE; CYTOKINE; DESIPRAMINE; DOPAMINE; FLUOXETINE; MONOAMINE; NORADRENALIN; SEROTONIN; VANOXERINE;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CELLULAR IMMUNITY; DRUG DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOMODULATION; INFECTION RISK; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; T LYMPHOCYTE;

COCAINE; HIV INFECTIONS; HUMANS; LYMPHOCYTES; SUBSTANCE-RELATED DISORDERS; VASOCONSTRICTOR AGENTS;

EID: 0032520729     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00230-0     Document Type: Article

References (52)

1. Anthony J.C., Vlahov D., Nelson K.E., Cohn S., Astemborski J., Solomon L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type I. Am. J. Epidemiol. 134:1991;1175-1189.
2. 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J. Immunol. 153:1994;489-498.
3. Bagasra O., Forman L. Functional analysis of lymphocyte subpopulations in experimental cocaine abuse: I. Dose-dependent activation of lymphocyte subsets. Clin. Exp. Immunol. 77:1989;289-293.
4. Baumann M.H., Gendron T.M., Becketts K.M., Henningfield J.E., Gorelick D.A., Rothman R.B. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol. Psychol. 38:1995;751-755.
5. Bayer B.M., Brehio R.M., Ding X.Z., Hernandez M.C. Enhanced susceptibility of the immune system to stress in morphine-tolerant rats. Brain Behav. Immun. 8:1994;173-184.
6. Bayer B.M., Mulroney S.E., Hernandez M.C., Ding X.Z. Acute infusions of cocaine result in time- and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology. 29:1995;19-28.
7. Bayer B.M., Hernandez M.C., Ding X.Z. Tolerance and crosstolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation. Pharmacol. Biochem. Behav. 53:1996;227-234.
8. Berkeley M.B., Daussin S., Hernandez M.C., Bayer B.M. In vitro effects of cocaine, lidocaine, and monoamine uptake inhibitors on lymphocyte proliferative responses. Immunopharmacol. Immunotoxicol. 16(2):1994;165-178.
9. Borowsky B., Kuhn C.M. GBR12909 stimulates hypothalamic-pituitary-adrenal activity by inhibition of uptake at hypothalamic dopamine neurons. Brain Res. 613:1993;251-258.
10. Chaisson R.E., Bacchetti P., Osmond D., Brodie B., Sande M.A., Moss A.R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 261:1989;561-565.
11. Chen G., Watson R.R. Modulation of tumor necrosis factor and gamma-interferon production by cocaine and morphine in aging mice infected with LP-BM5, a murine retrovirus. J. Leukocyte Biol. 50:1991;349-355.
12. Chiueh C.C., Kopin I.J. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the symphathoadrenal medullary system of unanesthetized rats. J. Pharmacol. Exp. Ther. 205:1978;148-154.
13. Darban, H., Watson, R.R., Alak, J., Thomas, N., 1993. Cocaine facilitation of Cryptosporidiosis by murine AIDS in male and female C57/BL/6 mice. Drugs of Abuse, Immunity, and AIDS, Plenum, New York, pp. 143-151.
14. Di Francesco P., Ralchetti R., Gaziano R., Lanzilli G., Belogi L., Ravagnan G., Garaci E. Differential effects of short-term or prolonged cocaine exposure on peripheral blood cells in mice. Life Sci. 54:1994;2015-2020.
15. Donahue et al., 1986.
16. Francesco P.D., Pica F., Marini S., Favalli C., Garaci E. Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration. Int. J. Immunopharmacol. 14:1991;1-9.
17. Havas H.F., Dellaria M., Schiffman G., Geller E.B., Adler M.W. Effect of cocaine on the immune response and host resistance in BALB/c mice. Int. Arch. Allergy Appl. Immunol. 83:1987;377-383.
18. Hellstrand K., Hermodsson S. Role of serotonin in the regulation of human natural killer cell cytotoxicity. J. Immunol. 139:1987;869-875.
19. Javaid J.I., Fischman M.W., Schuster C.R., Dekiermenjian H., Davis J.M. Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science. 202:1978;227-228.
20. Johanson C.-E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
21. Kaslow R.A., Blackwelder W.C., Ostrow W.C., Yerg D., Palenicek J., Coulson A.H., Valdiserri R.O. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals: A report from the multicenter AIDS cohort study. JAMA. 261:1989;3424-3429.
22. Kiristy-Roy J.A., Halter J.B., Gordon S.M., Smith M.J., Terry L.C. Role of central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J. Pharmacol. Exp. Ther. 255:1990;154-160.
23. Koenig J.I., Gudelsky G.A., Meltzer H.Y. Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur. J. Pharmacol. 137:1987;1-8.
24. Levy A.D., Baumann M.H., Van de Kar L.D. Monoaminergic regulation of neuroendocrine function and its modification by cocaine. Front. Neuroendocrinol. 15:1994;85-156.
25. Levy A.D., Li Q., Gustatson M., Van de Kar L.D. Neuroendocrine profile of the potential anxiolytic drug S-20499. Eur. J. Pharmacol. 274:1995;141-149.
26. Levy A.D., Li Q., Kerr J.E., Rittenhouse P.A., Milonas G., Cabrera T.M., Battaglia G., Alvarez Sanz M.C., Van de Kar L.D. Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons. J. Pharmacol. Exp. Ther. 259(2):1991;495-500.
27. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol. Psychol. 36:1994;300-308.
28. Lopez M.C., Columbo L.L., Huang D.S., Wang Y., Watson R.R. Modification of thymic cell subsets induced by long-term cocaine administration during a murine retroviral infection producing aids. Clin. Immunol. Immunopathol. 65:1992;45-52.
29. Lopez M.C., Watson R.R. Effect of cocaine and murine AIDS on lamina propria T and B cells in normal mice. Life Sci. 54:1994;PL147-PL151.
30. Lou Y.D., Patel M.K., Wiederhold M.D., Ou D.W. Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int. J. Immunopharmacol. 14:1992;49-56.
31. Madden K.S., Felten D.L. Experimental basis for neural-immune interactions. Pharmacol. Rev. 75:1995;77-106.
32. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influence and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35:1995;417-448.
33. Martinez F., Watson R.R. Effects of cocaine and morphine on IgG production by human peripheral blood lymphocytes in vitro. Life Sci. 47:1990;PL59-PL64.
34. Nordlind K., Sundstrom E., Bondesson L. Inhibiting effects of serotonin antagonists on the proliferation of mercuric chloride stimulated human peripheral blood T-lymphocytes. Int. Arch. Allergy Immunol. 97:1992;105-108.
35. Ou D.W., Shen M.-L., Luo Y.-D. Effects of cocaine on the immune system of Balb/c mice. Clin. Immunol. Immunopathol. 52:1989;305-312.
36. Parrillo J.E., Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Annu. Rev. Pharmacol. Toxicol. 19:1979;179-201.
37. Pellegrino T., Bayer B.M. Inhibition of serotonin reuptake mimics cocaine. Suppression of mitogen stimulated lymphocyte proliferation. FASEB. 10(3):1996;A450. abstract #2559.
38. Ritz et al., 1990.
39. Rivier C., Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF) mediated mechanism. Brain Res. 422:1987;403-406.
40. Ruiz P., Cleary T., Nassiri M., Steele B. Human T-lymphocyte subpopulations and NK cell alterations in persons exposed to cocaine. Clin. Immunol. Immunopathol. 70:1994;245-250.
41. Saphier D., Welch J.E., Farrar G.E., Goeders N.E. Effects of intracerebroventricular and intrahypothalamic cocaine administration on adrenocortical secretion. Neuroendocrinology. 57:1993;54-62.
42. Sarnyai Z., Biro E., Telegdy G. Cocaine-induced elevation of plasma corticosterone is mediated by different neurotransmitter systems in rats. Pharmacol. Biochem. Behav. 45:1993;209-214.
43. Sharkey J., Ritz M.C., Schenden J.A., Hanson R.C., Kuhar M.J. Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J. Pharmacol. Exp. Ther. 246:1988;1048-1052.
44. Stanulis E.D., Matulka R.A., Jordan S.D., Rosecrans J.A., Holsapple M.P. Role of corticosterone in the enhancement of the antibody response after acute cocaine administration. J. Pharmacol. Exp. Ther. 280:1996;284-291.
45. Starec et al., 1983.
46. Starec M., Riouveix B., Sinet M., Chau F., Desforges B., Pocidalo J.J., Lechat P. Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus. J. Pharmacol. Exp. Ther. 259:1991;745-750.
47. Szabo B., Obergfell A., Starke K. Involvement of monoamine inhibition and local anesthesia in the cardiovascular response to cocaine in conscious rabbits. J. Pharmacol. Exp. Ther. 273:1995;128-137.
48. Tella S.R., Schindler C.W., Goldberg S.R. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J. Pharmacol. Exp. Ther. 267:1993;153-162.
49. Van Dyke C., Stesin A., Jones R., Chonthrapal A., Seaman W. Cocaine increases natural killer cell activity. J. Clin. Invest. 77:1986;1387-1390.
50. Wang Y., Huang D.S., Watson R.R. In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci. 54:1994;401-411.
51. Welch W.D. Effect of cocaine on non-specific human cellular host defenses. Res. Commun. Subst. Abuse. 4:1983;1-9.
52. Watson E.S., Murphy J.C., ElSolhy H.N., ElSolhy M.A., Turner C.E. Effects of the administration of coca alkaloids on the primary immune responses of mice: interaction with tetrahydrocannabinol and ethanol. Toxicol. Appl. Pharmacol. 71:1983;1-13.